Læknablaðið

Ukioqatigiit

Læknablaðið - 01.04.1978, Qupperneq 15

Læknablaðið - 01.04.1978, Qupperneq 15
LÆKNABLAÐIÐ 49 ustu byrjunareinkenni eru frá lægri motor neuronum og mikið oftar í griplimum en ganglimum. í þessari byrjun sjúkdómsins eru fyrstu einkenni langoftast distalt og ríkjandi er symmetrisk útbreiðsla þeirra. Fæstir sjúklingarnir höíðu sögu um sjúk- dóma sem tilgátur hafa verið um sem frum- crsck eða meðvirkandi orsök í M.N.D. Nið- urstöður þessar eru allar svipaðar þeim sem annars staðar gerist að því þó undanskildu, að fleiri sjúklingar lifa hér lengur en ann- ars staðar með þennan sjúkdóm. Ellefu sjúklingar, 8 karlar og 3 konur, höfðu lif- að lengur en í 10 ár, þar af einn í 24 ár. Fimm þes.sara siðastöldu eru enn á lífi. Þrjátíu sjúklinganna fullnægðu sjúk- dómrgreiningunni ALS kliniskt, en 6 sjúk- dcmsgreiningunni PMA og 1 PLS. Niður- stöður benda tij þess að rök megi leiða að því að M.N.D. sé oftast ALS og oftar en talið hefur verið cg að hinar einstöku sjúkdómsmyndir M.N.D., sem ganga undir ýmsum sjúkdóm.sheitum, séu oftast und- anfarastig í ALS, sem sé þannig til í króniskri mynd. Tveir flokkar ALS finn- ast, þ.e. hinn tilfallandi (sporadic) og sá ættgengi. ALS sjúklingar hér hafa hins- vegar ekki sérkenni Guam-gerðarinnar hvað t'ðni og ættgengi viðkemur (sjúkdóm- urinn er þar 50—100 sinnum algengari en annars staðar). í beinu framhaldi er álykt- að. að þessar mismunandi sjúkdómsmyndir (PMMA, PMA, PLS og PBP) eigi sér sömu orsakir en ónæmisþættir og samsetning og efnaskipti motor neuron kerfis ákvarði kliniska útbreiðslu og hraða sjúkdómsins. Horfur virðast óháðar því frá hvaða hluta motor neurcn kerfisins fyrstu ein- kenni koma fram, en horfur á langlífi í sjúkdómnum eru meiri ef byrjunarein- kenni eru hægfara og ef einkenni koma seint fram frá fleiri en einum hluta motor neuron kerfisins. SUMMARY. The results of an epidemiological study on M N.D. in Iceland during the period 1951-1970 are presented. There are 37 patients, 22 men rnd 15 women. The M/F ratio is 1.47:1. The annual incidence is 0.8:100.000, the prevalence 6 5:100.000 at the end of the survey and the death rate is 0.7:100.000 per year. The farnily incidence is 5.5%. The disease is rare under the age of 40 and the peak onset age for both sexes was between the age of 50—60 years with mean-onset age for both sexes 55,5 years. The mean survival time for both sexes was 7 years, 5,47 years for women and 8 years for men. The most common inital symptom was that of lower motor neuron disease, found in 29 pati- ents. The disease process started in the upper limbs in 19 patients, in the lower limbs in 6, and in both upper and lower limbs simulta- neously in 4. There was dominantly distal initiai involvement in these cases. Only 2 patients had presented with symptoms of progressive lateral sclerosis and 6 patients presented with symptoms of progressive bulbar paresis. All patients except two had symmetrical symptoms and signs early in their disease. Fasciculations were present early in all patients except one. Thirty patients developed the classical picture of amyotropic lateral sclerosis, but on clinical grounds 6 patients were grouped as progressive muscular atrophy, never developing clinical evidence of upper motor neuron involvement. One patient had only evidence of pyramidal tract involment hence classified PLS. Regarding possible predisposing factors minor traumas were found in 3 patients. Seven natients had had gastric ulcers, 2 of them had had resection of the stomach. None of those patients had any clinical or biochemical evi- dence of malabsorption. Three patients had suf- fered from rheumatoid arthritis. One patient began his M.N.D. after vaccina- tion and an infectious disease similar to Ice- land (Akureyri) disease. No other suggested causative or predisposing factors were found. With the exception of the long mean survivai time these findings correspond to those re- ported by most authors. The cases of amyotrophic lateral sclerosis are all of the sporadic type, except 2 of the familial group. None of the cases of amyotro- phic lateral sclerosis had any resemblance to the familial amyotrophic lateral sclerosis patients of Guam. Different from the results of all other sur- veys is a relatively high number of patients living for more than 10 years. Eleven patients, 8 men and 3 women lived 11—24 years, 5 of them being still alive in 1976 The Ivgh proportion of AL3 suggests that mo"t cases of M.N.D. are ALS and that cases described as PMMA, PMA, PLS and PBP are oniy precursors of ALS. Slowly progressing cases under these headings might as well be called chronic ALS. This view is supported by the fact that 9 of the 11 cases surviving more than 10 years gradually developed the classical picture of ALS, although they might earlier in the course of their disease have been correctly called clinically PMMA and Lter PMA. It is also strengthened by the fact tb°t 3 cases that had failed to show clinicaliy anv evidence of upper motor neuron involve- me "t had clear evidenco cf cortico-spinal tracts involvement of post mortem examination.
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100
Qupperneq 101
Qupperneq 102
Qupperneq 103
Qupperneq 104
Qupperneq 105
Qupperneq 106
Qupperneq 107
Qupperneq 108
Qupperneq 109
Qupperneq 110

x

Læknablaðið

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið
https://timarit.is/publication/986

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.